Concepedia

Multicenter Trial Approval

Multicenter Trial Approval is a formal authorization granted by a regulatory or ethical review body permitting the simultaneous conduct of a clinical trial across multiple geographically distinct sites, distinguished from single-center approval by its requirement for harmonized oversight, standardized protocols, and centralized coordination to ensure consistency and regulatory compliance across all participating centers.

174

Publications

15.3K

Citations

1.7K

Authors

774

Institutions

Publications per year

2017–2026

66

Parents

Publications

174

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Johannes Oldenburg, Johnny Mahlangu, Benjamin Kim et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

, , +16

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Elise A. Olsen, Youn H. Kim, Timothy M. Kuzel et al. · Journal of Clinical Oncology · 2007 · 1K citations

, , +16

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

Edward Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine · 2005 · 890 citations · Full text

, , +17

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

Toni K. Choueiri, Susan Halabi, Ben L. Sanford et al. · Journal of Clinical Oncology · 2017 · 715 citations

, , +14

FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors

Leigh Marcus, Lola A. Fashoyin‐Aje, Martha Donoghue et al. · Clinical Cancer Research · 2021 · 568 citations · Full text

, , +17

1–5 of 174

Authors

1.7K

  1. RP
    Richard Pazdur

    United States Food and Drug Administration, United States

    13 publications · 1.7K citations

    13

    h-index

  2. MR
    Marc R. Theoret

    United States Food and Drug Administration, United States

    5 publications · 729 citations

    5

    h-index

  3. RS
    Rajeshwari Sridhara

    United States Food and Drug Administration, United States

    4 publications · 471 citations

    4

    h-index

  4. AH
    Axel Hauschild

    University of Lübeck, Germany

    4 publications · 121 citations

    4

    h-index

  5. PR
    Piotr Rutkowski

    The Maria Sklodowska-Curie National Research Institute of Oncology, Poland

    4 publications · 451 citations

    4

    h-index

1–5 of 1.7K

Institutions

774

  1. United States Food and Drug Administration

    Silver Spring, United States

    17 h-index

    165 publications

    17.2K citations

  2. Center for Drug Evaluation and Research

    Silver Spring, United States

    14 h-index

    105 publications

    10.3K citations

  3. Dana-Farber Cancer Institute

    Boston, United States

    10 h-index

    66 publications

    11.8K citations

  4. Massachusetts General Hospital

    Boston, United States

    10 h-index

    31 publications

    1.7K citations

  5. Harvard University

    Cambridge, United States

    7 h-index

    12 publications

    1.4K citations

  6. University of Pennsylvania

    Philadelphia, United States

    7 h-index

    11 publications

    307 citations

  7. Memorial Sloan Kettering Cancer Center

    New York, United States

    7 h-index

    10 publications

    396 citations

  8. Emory University

    Atlanta, United States

    7 h-index

    20 publications

    12K citations

1–8 of 774

Venues

  1. Journal of Clinical Oncology

    17 publications · 3.3K citations

    14

    h-index

  2. Clinical Cancer Research

    10 publications · 1.5K citations

    10

    h-index

  3. Annals of Oncology

    10 publications · 808 citations

    9

    h-index

  4. PubMed

    Repository · 7 publications · 193 citations

    7

    h-index

  5. Blood

    5 publications · 148 citations

    5

    h-index

1–5